Tumor diversity and evolution revealed through RADseq

Cancer is an evolutionary disease, and there is increasing interest in applying tools from evolutionary biology to understand cancer progression. Restriction-site associated DNA sequencing (RADseq) was developed for the field of evolutionary genetics to study adaptation and identify evolutionary rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Perry, Elizabeth B., Makohon-Moore, Alvin, Zheng, Caihong, Kaufman, Charles K., Cai, Jun, Iacobuzio-Donahue, Christine A., White, Richard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Priority Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522028/
https://www.ncbi.nlm.nih.gov/pubmed/28611298
http://dx.doi.org/10.18632/oncotarget.18355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522028/
https://www.ncbi.nlm.nih.gov/pubmed/28611298
http://dx.doi.org/10.18632/oncotarget.18355

Ejemplares similares